Abstract LB284: VRN101099: A novel treatment option for HER2-driven cancer patients, overcoming T-DXd resistance and brain metastases
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-lb284
Abstract: Many systemic therapeutic options for advanced metastatic HER2-positive breast cancer have been approved, including antibody-based therapies, chemotherapies, and tyrosine kinase inhibitors (TKIs). However, brain metastasis and acquired resistance are still major unmet medical needs for… read more here.
Keywords: vrn101099; cancer; resistance; brain ... See more keywords